Additionally, miR21-5p and miR-96-5p target SMAD7, which is linked to “fibrosis of the liver” [76], “proliferation of liver cells”, “proliferation of hepatocytes”, “diabetes mellitus”, and “glucose metabolism disorder”. Here, SMAD7 is linked to diabetes mellitus.